Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC1 | Q13547 | 17/20 | 0.65 |
| ▸ | HDAC2 | Q92769 | 6/20 | 0.65 |
| ▸ | HDAC3 | O15379 | 5/20 | 0.65 |
| ▸ | NPC1 | O15118 | 1/20 | 0.58 |
| ▸ | RAB9A | P51151 | 1/20 | 0.58 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4581935 | 0.90 | HDAC1 (0.79) | HDAC1HDAC2HDAC3KCNH2 | |
| SCHEMBL4580198 | 0.89 | HDAC1 (0.82) | HDAC1HDAC2HDAC3KCNH2 | |
| SCHEMBL4578711 | 0.87 | HDAC1 (0.84) | HDAC1HDAC2HDAC3KCNH2 | |
| SCHEMBL4579434 | 0.86 | HDAC1 (0.70) | HDAC1HDAC2HDAC3KCNH2 | |
| SCHEMBL18670964 | 0.86 | HDAC1 (0.64) | HDAC1HDAC2HDAC3KCNH2 | |
| SCHEMBL18653509 | 0.86 | HDAC2 (0.75) | HDAC1HDAC2HDAC3 | |
| SCHEMBL2137319 | 0.84 | HDAC1 (0.76) | HDAC1HDAC2HDAC3 | |
| SCHEMBL18670967 | 0.84 | HDAC1 (0.82) | HDAC1HDAC2HDAC3 | |
| SCHEMBL1065833 | 0.84 | ABCB1 (0.73) | HDAC1HDAC2HDAC3RAB9A | |
| SCHEMBL4578313 | 0.84 | HDAC1 (0.83) | HDAC1HDAC2HDAC3KCNH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9603950-B1 | Compounds of imaging agent with HDAC inhibitor for treatment of Alzheimer syndrome and method of synthesis thereof | INSTITUTE OF NUCLEAR ENERGY RESEARCH (TW) | 2017-03-28 | — | — | US | disclosed |
| US-9603950-B1 | Compounds of imaging agent with HDAC inhibitor for treatment of Alzheimer syndrome and method of synthesis thereof | INSTITUTE OF NUCLEAR ENERGY RESEARCH (TW) | 2017-03-28 | — | — | US | disclosed |